Navigation Links
James C. Powell Joins Nerites Board of Directors
Date:7/29/2008

MADISON, Wis., July 29 /PRNewswire/ -- James C. Powell, former President and Chief Operating Officer of SurModics Inc., has joined the Board of Directors of Nerites Corporation.

Under Powell's guidance, SurModics developed medical device coatings and consummated dozens of corporate partnerships to commercialize products. Powell joined SurModics in 1987 as the Director of Coatings Product Development; he helped lead the company's transition from a diagnostics kit manufacturer to a developer of surface modification technologies. In 1998, the company made its initial public offering (IPO) and Powell became President. He retired in 2003, at a time when the company's market capitalization reached $675 Million.

"We're extremely pleased to welcome Jim to Nerites," stated George Arida, Chairman of the Board of Directors. "His extensive experience forming profitable corporate partnerships with major medical device companies will be valuable to us. We're excited about the depth of expertise and relationships that Jim brings to our board as we begin working with corporate partners to commercialize our adhesives, sealants, and coatings for specific medical indications."

"Nerites is an exciting opportunity," stated Powell. "With strong management and a unique technology advantage, Nerites seems prepared for success. I'm looking forward to contributing my experience wherever it may be useful." James C. Powell holds a Bachelor of Science degree from Texas A&M University and a Master's degree from the University of Washington.

About Nerites:

Nerites Corporation develops fully-synthetic, water-resistant adhesives, sealants, and coatings for internal medical use. The hydrogel technology can be used to close internal tears or incisions, to seal tissues and prevent leakage and infection, and to affix synthetic or biologic medical devices. Properties can be "tuned" to fit each application. The technology was described with a cover article in the journal Nature (July, 2007) and was labeled "one of the top 100 scientific developments of 2007" by Discover Magazine. (http://www.Nerites.com)


'/>"/>
SOURCE Nerites
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
2. Orchid Cellmark Appoints James F. Smith Chief Financial Officer
3. Immunotec Inc. announces appointment of President & CEO James A. Northrop
4. Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
5. James Webb Space Telescope marks successful completion
6. IRIDEX Announces James Mackaness Will Be Chief Financial Officer
7. Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
8. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
9. Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference
10. Warner Chilcott Reports the Death of Its Director James Andress
11. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... oncology and dermatology biopharmaceutical company, today is providing ... its previously announced rights offering of up to ... stock and Series C Convertible Preferred Stock to ... As previously announced, the rights offering ...
(Date:2/24/2017)... ... 24, 2017 , ... FireflySci, Inc is an explosive small business that continues ... goal of bringing their powerful cuvette and spectrophotometer calibration to the spectroscopy ... is going on as they add yet another mark on the global map. , ...
(Date:2/23/2017)... RAFAEL, Calif., Feb. 23, 2017 ... U.S. dollars, except per share data, unaudited)Three Months Ended ... ChangeTotal BioMarin Revenue $   ...   22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... 2017  Seattle,s upscale Capitol Hill neighborhood, with its swanky shops, ... a head lice treatment salon to set up shop. But ... and a French bistro on E Madison Ave, and CEO ... any old lice clinic, we pride ourselves on being a ... some of the stigma associated with lice. Everyone can get ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
Breaking Biology News(10 mins):